Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.

Exclusion Criteria

• •1. Signs of active infection on the ocular surface.
• •2. History of neoplasms in the last 5 years. except for epithelial basal or squamous cell carcinoma
• •3. Allergy to local anesthetics
• •4. Patients who have participated in another clinical trial with medication during the 90 days prior to signing the IC
• •5. Medical or psychiatric illness of any kind that, in the opinion of the investigator, may be a reason for exclusion from the study.
• •6. Congenital or acquired immunodeficiencies.
• •7. Major surgery or serious trauma of the subject in the semester prior to signing the IC.
• •8. Pregnant or lactating women.
• •9. Impossibility or refusal to carry out the follow-up required in the study by the patient